Dr. Jean Louis Selam is CEO of the Diabetes Research Center in Tustin, California, a role he has served in since 2006. He has published peer-reviewed papers, articles, and delivered conference presentations, primarily in the field of new insulin therapy techniques, including intensive insulin and implantable insulin pumps. He also has performed pioneer work on intraperitoneal insulin and insulin-induced remissions.